Skip to main content
SpringerLink
Log in
Book cover

Musculoskeletal Tissue Regeneration pp 619–634Cite as

The Future of Musculoskeletal Tissue Regeneration: A Clinical Perspective

  • Chapter

  • 1709 Accesses

Part of the book series: Orthopedic Biology and Medicine ((OBM))

Abstract

Over the past decade significant advances have occurred with our understanding of the molecular pathways related to the repair for hard and soft tissues of the musculoskeletal system. It is essential that this information be translated from the bench to the bedside to create novel treatment regimens that advance the care of patients. The purpose of this chapter is to elucidate therapeutic regimens that may be developed in the future. Over the next two to 10 years there will be an intense focus on developing targeted delivery of bioactive substances that employ minimally invasive surgical techniques. Treatments in the remote future will require knowledge related to the host biologic potential, disease risk stratification and prevention strategies for the musculoskeletal patient. A case study is presented to explore the potential clinical future.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   299.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. 1. Bianco P, Gehron Robey P. Marrow stromal stem cells. J Clin Invest. 2000 Jun;105(12):1663–8.

    Article  PubMed  CAS  Google Scholar 

  2. 2. Tagliafico E, Brunelli S, Bergamaschi A, De Angelis L, Scardigli R, Galli D, Battini R, Bianco P, Ferrari S, Cossu G, Ferrari S. TGFbeta/BMP activate the smooth muscle/bone differentiation programs in mesoangioblasts. J Cell Sci. 2004 Sep 1;117(Pt 19):4377–88.

    Article  PubMed  CAS  Google Scholar 

  3. 3. Kawamoto A, Gwon HC, Iwaguro H, Yamaguchi JI, Uchida S, Masuda H, Silver M, Ma H, Kearney M, Isner JM, Asahara T. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation. 2001 Feb 6;103(5):634–7.

    PubMed  CAS  Google Scholar 

  4. 4. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, Reyes M, Lenvik T, Lund T, Blackstad M, Du J, Aldrich S, Lisberg A, Low WC, Largaespada DA, Verfaillie CM. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature. 2002 Jul 4;418(6893):41–9. Epub 2002 Jun 20.

    Article  PubMed  CAS  Google Scholar 

  5. 5. Nilsson SK, Simmons PJ. Transplantable stem cells: home to specific niches. Curr Opin Hematol. 2004 Mar;11(2):102–6. Review.

    Article  PubMed  Google Scholar 

  6. 6. Dragoo JL, Lieberman JR, Lee RS, Deugarte DA, Lee Y, Zuk PA, Hedrick MH, Benhaim P. Tissue-engineered bone from BMP-2-transduced stem cells derived from human fat. Plast Reconstr Surg. 2005 May;115(6):1665–73.

    Article  PubMed  CAS  Google Scholar 

  7. 7. Hernigou P, Poignard A, Beaujean F, Rouard H. Percutaneous autologous bone-marrow grafting for nonunions. Influence of the number and concentration of progenitor cells. J Bone Joint Surg Am. 2005 Jul;87(7):1430–7.

    Article  PubMed  Google Scholar 

  8. 8. Ramalho-Santos M, Yoon S, Matsuzaki Y, Mulligan RC, Melton DA. “ Stemness” : transcriptional profiling of embryonic and adult stem cells. Science. 2002 Oct 18;298(5593):597–600.

    Article  PubMed  CAS  Google Scholar 

  9. 9. Aslan H, Zilberman Y, Kandel L, Liebergall M, Oskouian RJ, Gazit D, Gazit Z. Osteogenic differentiation of noncultured immunoisolated bone marrow-derived CD105+ cells. Stem Cells. 2006 Jul;24(7):1728–37.

    Article  PubMed  Google Scholar 

  10. Anastasia L, Sampaolesi M, Papini N, Oleari D, Lamorte G, Tringali C, Monti E, Galli D, Tettamanti G, Cossu G, Venerando B. Reversine-treated fibroblasts acquire myogenic competence in vitro and in regenerating skeletal muscle. Cell Death Differ. 2006 May 26.

    Google Scholar 

  11. Kurtz SM, Lau E, Mowat F, Ong K, Halpern, MT. The Future Burden of Hip and Knee Revisions: U.S. Projections from 2005 to 2030. AAOS 2006 Annual Meeting: Paper 403. Presented March 24, 2006. Electronic publication: http://www.aaos.org/ education/*anmeet/anmt2006/podium/podium.cfm?* Pevent=403 (accessed Dec 20, 2006).

    Google Scholar 

  12. Gan Q, Yoshida T, McDonald OG, Owens GK. Epigenetic Mechanisms Contribute to Pluripotency and Cell Lineage Determination of Embryonic Stem Cells. Stem Cells. 2006 Oct 5. (Electronic publication ahead of print)

    Google Scholar 

  13. 13. Urist MR, Mikulski A, Lietze A. Solubilized and insolubilized bone morphogenetic protein. Proc Natl Acad Sci U S A. 1979 Apr;76(4):1828–32.

    Article  PubMed  CAS  Google Scholar 

  14. 14. Shaw NJ, Fraser NC, Rose S, Crabtree NJ, Boivin CM. Bone density and body composition in children with growth hormone insensitivity syndrome receiving recombinant IGF-I. Clin Endocrinol (Oxf). 2003 Oct;59(4):487–91.

    Article  CAS  Google Scholar 

  15. 15. Steed DL. Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity ulcers. Plast Reconstr Surg. 2006 Jun;117 (7 Suppl):143S–149S.

    Article  PubMed  CAS  Google Scholar 

  16. 16. Spivak JL, Ferris DK, Fisher J, Noga SJ, Isaacs M, Connor E, Hankins WD. Cell cycle-specific behavior of erythropoietin. Exp Hematol. 1996 Feb;24(2):141–50.

    PubMed  CAS  Google Scholar 

  17. 17. Boden SD, Kang J, Sandhu H, Heller JG. Use of recombinant human bone mor-phogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies. Spine. 2002 Dec 1;27(23):2662–73.

    Article  PubMed  Google Scholar 

  18. 18. Govender S, Csimma C, Genant HK, Valentin-Opran A, Amit Y, Arbel R, Aro H, Atar D, Bishay M, Borner MG, Chiron P, Choong P, Cinats J, Courtenay B, Feibel R, Geulette B, Gravel C, Haas N, Raschke M, Hammacher E, van der Velde D, Hardy P, Holt M, Josten C, Ketterl RL, Lindeque B, Lob G, Mathevon H, McCoy G, Marsh D, Miller R, Munting E, Oevre S, Nordsletten L, Patel A, Pohl A, Rennie W, Reynders P, Rommens PM, Rondia J, Rossouw WC, Daneel PJ, Ruff S, Ruter A, Santavirta S, Schildhauer TA, Gekle C, Schnettler R, Segal D, Seiler H, Snowdowne RB, Stapert J, Taglang G, Verdonk R, Vogels L, Weckbach A, Wentzensen A, Wisniewski T; BMP-2 Evaluation in Surgery for Tibial Trauma (BESTT) Study Group. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am. 2002 Dec;84-A(12):2123–34.

    PubMed  Google Scholar 

  19. 19. Sherwin RS, Borg WP, Boulware SD. Metabolic effects of insulin-like growth factor-1 in normal humans. Horm Res 1994;41 (suppl 2): 97–102.

    Article  PubMed  CAS  Google Scholar 

  20. 20. Nevins M, Giannobile WV, McGuire MK, Kao RT, Mellonig JT, Hinrichs JE, McAllister BS, Murphy KS, McClain PK, Nevins ML, Paquette DW, Han TJ, Reddy MS, Lavin PT, Genco RJ, Lynch SE. Platelet-derived growth factor stimulates bone fill and rate of attachment level gain: results of a large multicenter randomized controlled trial. J Periodontol. 2005 Dec;76(12):2330–2.

    Article  Google Scholar 

  21. 21. Ranly DM, McMillan J, Keller T, Lohmann CH, Meunch T, Cochran DL, Schwartz Z, Boyan BD. Platelet-derived growth factor inhibits demineralized bone matrix-induced intramuscular cartilage and bone formation. A study of immunocompromised mice. J Bone Joint Surg Am. 2005 Sep;87(9):2052–64.

    Article  PubMed  Google Scholar 

  22. 22. Gallea S, Lallemand F, Atfi A, Rawadi G, Ramez V, Spinella-Jaegle S, Kawai S, Faucheu C, Huet L, Baron R, Roman-Roman S. Activation of mitogen-activated protein kinase cascades is involved in regulation of bone morphogenetic protein-2-induced osteoblast differentiation in pluripotent C2C12 cells. Bone. 2001 May;28(5):491–8.

    Article  PubMed  CAS  Google Scholar 

  23. 23. Dudley AT, Godin RE, Robertson EJ Interaction between FGF and BMP signaling pathways regulates development of metanephric mesenchyme. Genes Dev. 1999 Jun 15;13(12):1601–13.

    Article  PubMed  CAS  Google Scholar 

  24. 24. Puzas JE, O' Keefe RJ, Lieberman JR. The orthopaedic genome: what does the future hold and are we ready? J Bone Joint Surg Am. 2002 Jan;84-A(1):133–41.

    PubMed  Google Scholar 

  25. 25. Melton L: Protein arrays: Proteomics in multiplex. Nature 2004; 429: 101–107.

    Article  PubMed  Google Scholar 

  26. 26. Gardiner SJ, Begg EJ. Pharmacogenetics, drug-metabolizing enzymes, and clinical practice. Pharmacol Rev. 2006 Sep;58(3):521–90.

    Article  PubMed  CAS  Google Scholar 

  27. 27. Baltzer AW, Lieberman JR. Regional gene therapy to enhance bone repair. Gene Ther. 2004 Feb;11(4):344–50. Review.

    Article  PubMed  CAS  Google Scholar 

  28. 28. Lieberman JR, Ghivizzani SC, Evans CH. Gene transfer approaches to the healing of bone and cartilage. Mol Ther. 2002 Aug;6(2):141–7. Review.

    Article  PubMed  CAS  Google Scholar 

  29. 29. O' Keefe DS, Uchida A, Bacich DJ, Watt FB, Martorana A, Molloy PL, Heston WD. Prostate-specific suicide gene therapy using the prostate-specific membrane antigen promoter and enhancer. Prostate. 2000 Oct 1;45(2):149–57.

    Article  PubMed  Google Scholar 

  30. 30. Li X, Zhang J, Gao H, Vieth E, Bae KH, Zhang YP, Lee SJ, Raikwar S, Gardner TA, Hutchins GD, VanderPutten D, Kao C, Jeng MH. Transcriptional targeting modalities in breast cancer gene therapy using adenovirus vectors controlled by alpha-lactalbumin promoter. Mol Cancer Ther. 2005 Dec;4(12):1850–9.

    Article  PubMed  CAS  Google Scholar 

  31. 31. Nakagawa S, Massie B, Hawley RG. Tetracycline-regulatable adenovirus vectors: pharmacologic properties and clinical potential. Eur J Pharm Sci. 2001 Apr;13(1):53–60. Review.

    Article  PubMed  CAS  Google Scholar 

  32. 32. Check E. Cancer risk prompts US to curb gene therapy. Nature. 2003 Mar 6;422(6927):7.

    Article  PubMed  CAS  Google Scholar 

  33. 33. Minamide A, Kawakami M, Hashizume H, Sakata R, Tamaki T. Evaluation of carriers of bone morphogenetic protein for spinal fusion.. Spine. 2001 Apr 15;26(8):933–9.

    Article  PubMed  CAS  Google Scholar 

  34. 34. Peterson B, Whang PG, Iglesias R, Wang JC, Lieberman JR. Osteoinductivity of commercially available demineralized bone matrix. Preparations in a spine fusion model. J Bone Joint Surg Am. 2004 Oct;86-A(10):2243–50.

    PubMed  Google Scholar 

  35. Oakes DA, Lee CC, Lieberman JR. An evaluation of human demineralized bone matrices in a rat femoral defect model. Clin Orthop Relat Res. 2003 Aug;(413):281–90.

    Google Scholar 

  36. 36. Webster TJ, Ergun C, Doremus RH, Siegel RW, Bizios R. Enhanced functions of osteoblasts on nanophase ceramics. Biomaterials. 2000 Sep;21(17):1803–10.

    Article  PubMed  CAS  Google Scholar 

  37. 37. Webster TJ, Schadler LS, Siegel RW, Bizios R. Mechanisms of enhanced osteoblast adhesion on nanophase alumina involve vitronectin. Tissue Eng. 2001 Jun;7(3):291–301.

    Article  PubMed  CAS  Google Scholar 

  38. 38. J.B. Thomas, N.A. Peppas, M. Sato, and T.J. Webster. Nanotechnology and Biomaterials in CRC Nanomaterials Handbook, Y. Gogotsi ed. CRC Press, Boca Raton, 2005.

    Google Scholar 

  39. 39. Manjubala I, Woesz A, Pilz C, Rumpler M, Fratzl-Zelman N, Roschger P, Stampfl J, Fratzl P. Biomimetic mineral-organic composite scaffolds with controlled internal architecture. J Mater Sci Mater Med. 2005 Dec;16(12):1111–9.

    Article  PubMed  CAS  Google Scholar 

  40. 40. Friess W, Uludag H, Foskett S, Biron R, Sargeant C. Characterization of absorbable collagen sponges as recombinant human bone morphogenetic protein-2 carriers. Int J Pharm, 1999;185: 51–60.

    Article  PubMed  CAS  Google Scholar 

  41. 41. Mann V, Ralston SH. Meta-analysis of COL1A1 Sp1 polymorphism in relation to bone mineral density and osteoporotic fracture. Bone. 2003 Jun;32(6):711–7.

    Article  PubMed  CAS  Google Scholar 

  42. 42. Liu YJ, Shen H, Xiao P, Xiong DH, Li LH, Recker RR, Deng HW. Molecular genetic studies of gene identification for osteoporosis: a 2004 update. J Bone Miner Res. 2006 Oct;21(10):1511–35.

    Article  PubMed  CAS  Google Scholar 

  43. 43. Duncan EL, Cardon LR, Sinsheimer JS, Wass JA, Brown MA. Site and gender specificity of inheritance of bone mineral density. J Bone Miner Res. 2003 Aug;18(8):1531–8.

    Article  PubMed  Google Scholar 

  44. 44. Pocock NA, Eisman JA, Mazess RB, Sambrook PN, Yeates MG, Freund J. Bone mineral density in Australia compared with the United States. J Bone Miner Res. 1988 Dec;3(6):601–4.

    Article  PubMed  CAS  Google Scholar 

  45. 45. Arden NK, Baker J, Hogg C, Baan K, Spector TD. The heritability of bone mineral density, ultrasound of the calcaneus and hip axis length: a study of postmenopausal twins. J Bone Miner Res. 1996 Apr;11(4):530–4.

    Article  PubMed  CAS  Google Scholar 

  46. 46. Garnero P, Arden NK, Griffiths G, Delmas PD, Spector TD. Genetic influence on bone turnover in postmenopausal twins. J Clin Endocrinol Metab. 1996 Jan;81(1):140–6.

    Article  PubMed  CAS  Google Scholar 

  47. 47. MacInnis RJ, Cassar C, Nowson CA, Paton LM, Flicker L, Hopper JL, Larkins RG, Wark JD. Determinants of bone density in 30- to 65-year-old women: a co-twin study. J Bone Miner Res. 2003 Sep;18(9):1650–6.

    Article  PubMed  CAS  Google Scholar 

  48. 48. Gong Y, Slee RB, Fukai N, Rawadi G, Roman-Roman S, Reginato AM, Wang H, Cundy T, Glorieux FH, Lev D, Zacharin M, Oexle K, Marcelino J, Suwairi W, Heeger S, Sabatakos G, Apte S, Adkins WN, Allgrove J, Arslan-Kirchner M, Batch JA, Beighton P, Black GC, Boles RG, Boon LM, Borrone C, Brunner HG, Carle GF, Dallapiccola B, De Paepe A, Floege B, Halfhide ML, Hall B, Hennekam RC, Hirose T, Jans A, Juppner H, Kim CA, Keppler-Noreuil K, Kohlschuetter A, LaCombe D, Lambert M, Lemyre E, Letteboer T, Peltonen L, Ramesar RS, Romanengo M, Somer H, Steichen-Gersdorf E, Steinmann B, Sullivan B, Superti-Furga A, Swoboda W, van den Boogaard MJ, Van Hul W, Vikkula M, Votruba M, Zabel B, Garcia T, Baron R, Olsen BR, Warman ML; Osteoporosis-Pseudoglioma Syndrome Collaborative Group. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell. 2001 Nov 16;107(4):513–23.

    Article  PubMed  CAS  Google Scholar 

  49. 49. Gong Y, Vikkula M, Boon L, Liu J, Beighton P, Ramesar R, Peltonen L, Somer H, Hirose T, Dallapiccola B, De Paepe A, Swoboda W, Zabel B, Superti-Furga A, Steinmann B, Brunner HG, Jans A, Boles RG, Adkins W, van den Boogaard MJ, Olsen BR, Warman ML. Osteoporosis-pseudoglioma syndrome, a disorder affecting skeletal strength and vision, is assigned to chromosome region 11q12–13. Am J Hum Genet. 1996 Jul;59(1):146–51.

    PubMed  CAS  Google Scholar 

  50. 50. Koay MA, Woon PY, Zhang Y, Miles LJ, Duncan EL, Ralston SH, Compston JE, Cooper C, Keen R, Langdahl BL, MacLelland A, O' Riordan J, Pols HA, Reid DM, Uitterlinden AG, Wass JA, Brown MA. Influence of LRP5 polymorphisms on normal variation in BMD. J Bone Miner Res. 2004 Oct;19(10):1619–27.

    Article  PubMed  CAS  Google Scholar 

  51. 51. Wilkinson JM, Wilson AG, Stockley I, Scott IR, Macdonald DA, Hamer AJ, Duff GW, Eastell R. Variation in the TNF gene promoter and risk of osteolysis after total hip arthroplasty. J Bone Miner Res. 2003 Nov;18(11):1995–2001.

    Article  PubMed  CAS  Google Scholar 

  52. 52. Hausler KD, Horwood NJ, Chuman Y, Fisher JL, Ellis J, Martin TJ, Rubin JS, Gillespie MT. J Bone Miner Res. Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation. 2004 Nov;19(11):1873–81.

    Article  PubMed  CAS  Google Scholar 

  53. 53. Skipor AK, Campbell PA, Patterson LM, Anstutz HC, Schmalzried TP, Jacobs JJ. Serum and urine metal levels in patients with metal-on-metal surface arthroplasty. J Mater Sci Mater Med. 2002 Dec;13(12):1227–34.

    Article  PubMed  CAS  Google Scholar 

  54. 54. Granchi D, Verri E, Ciapetti G, Stea S, Savarino L, Sudanese A, Mieti M, Rotini R, Dallari D, Zinghi G, Montanaro L. Bone-resorbing cytokines in serum of patients with aseptic loosening of hip prostheses. J Bone Joint Surg Br. 1998 Sep;80(5):912–7.

    Article  PubMed  CAS  Google Scholar 

  55. 55. Hallab NJ, Anderson S, Stafford T, Glant T, Jacobs JJ. Lymphocyte responses in patients with total hip arthroplasty. J Orthop Res. 2005 Mar;23(2):384–91.

    Article  PubMed  CAS  Google Scholar 

  56. Moore, G. Cramming more components onto integrated circuits. Electronics Magazine 19 April 1965.

    Google Scholar 

  57. 57. Boden SD, Einhorn TA, Morgan TS, Tosi LL, Weinstein JN. An AOA Critical Issue. The Future of the Orthopaedic Surgeon–Proceduralist or Keeper of the Musculoskeletal System? J Bone Joint Surg Am, Dec 2005; 87: 2812–2821.

    Article  PubMed  Google Scholar 

  58. 58. Chevalley T, Hoffmeyer P, Bonjour JP, Rizzoli R. An osteoporosis clinical pathway for the medical management of patients with low-trauma fracture. Osteoporos Int. 2002;13(6):450–5.

    Article  PubMed  CAS  Google Scholar 

  59. 59. Adami S, Isaia G, Luisetto G, Minisola S, Sinigaglia L, Gentilella R, Agnusdei D, Iori N, Nuti R; on behalf of ICARO Study Group. Fracture incidence and characterization in patients on osteoporosis treatment: the ICARO study. J Bone Miner Res. 2006 Oct;21(10):1565–70.

    Article  PubMed  CAS  Google Scholar 

  60. 60. Collins FS. Shattuck lecture–medical and societal consequences of the Human Genome Project. N Engl J Med. 1999 Jul 1;341(1):28–37.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Orthopaedic Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA

    Anna V. Cuomo

  2. New England Musculoskeletal Institute, Professor and Chairman, Department of Orthopaedic Surgery, University of Connecticut Health Center, Farmington, CT

    Jay R. Lieberman

Authors
  1. Anna V. Cuomo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jay R. Lieberman
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Bioengineering, University of Illinois at Chicago, Chicago, IL, USA

    William S. Pietrzak Ph.D.

  2. Biomet, Inc., Warsaw, IN, USA

    William S. Pietrzak Ph.D.

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Humana Press, a part of Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Cuomo, A.V., Lieberman, J.R. (2008). The Future of Musculoskeletal Tissue Regeneration: A Clinical Perspective . In: Pietrzak, W.S. (eds) Musculoskeletal Tissue Regeneration. Orthopedic Biology and Medicine. Humana Press. https://doi.org/10.1007/978-1-59745-239-7_29

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-239-7_29

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-909-3

  • Online ISBN: 978-1-59745-239-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation